These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 1581495)

  • 1. Bartlett-corrected tests for varying precision beta regressions with application to environmental biometrics.
    Guedes AC; Cribari-Neto F; Espinheira PL
    PLoS One; 2021; 16(6):e0253349. PubMed ID: 34181678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advice on comparing two independent samples of circular data in biology.
    Landler L; Ruxton GD; Malkemper EP
    Sci Rep; 2021 Oct; 11(1):20337. PubMed ID: 34645855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multivariate cure model for left-censored and right-censored data with application to colorectal cancer screening patterns.
    Hagar YC; Harvey DJ; Beckett LA
    Stat Med; 2016 Aug; 35(19):3347-67. PubMed ID: 26990553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size calculation for the proportional hazards cure model.
    Wang S; Zhang J; Lu W
    Stat Med; 2012 Dec; 31(29):3959-71. PubMed ID: 22786805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating Cure Rates From Survival Data: An Alternative to Two-Component Mixture Models.
    Tsodikov AD; Ibrahim JG; Yakovlev AY
    J Am Stat Assoc; 2003 Dec; 98(464):1063-1078. PubMed ID: 21151838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical receiver operating characteristic curve for two-sample comparison with cure fractions.
    Zhao X; Zhou X
    Lifetime Data Anal; 2010 Jul; 16(3):316-32. PubMed ID: 20221802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gini concentration test for survival data.
    Bonetti M; Gigliarano C; Muliere P
    Lifetime Data Anal; 2009 Dec; 15(4):493-518. PubMed ID: 19728088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-sample statistics for testing the equality of survival functions against improper semi-parametric accelerated failure time alternatives: an application to the analysis of a breast cancer clinical trial.
    Broët P; Tsodikov A; De Rycke Y; Moreau T
    Lifetime Data Anal; 2004 Jun; 10(2):103-20. PubMed ID: 15293627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The large sample distribution of the weighted log rank statistic under general local alternatives.
    Ewell M; Ibrahim JG
    Lifetime Data Anal; 1997; 3(1):5-12. PubMed ID: 9384622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing for the presence of cured patients: a simulation study.
    Peng Y; Dear KB; Carriere KC
    Stat Med; 2001 Jun; 20(12):1783-96. PubMed ID: 11406841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpreting statistical evidence with empirical likelihood functions.
    Zhang Z
    Biom J; 2009 Aug; 51(4):710-20. PubMed ID: 19650056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of tests of the difference in the proportion of patients who are cured.
    Sposto R; Sather HN; Baker SA
    Biometrics; 1992 Mar; 48(1):87-99. PubMed ID: 1581495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing approaches for overdispersion in poisson regression versus the generalized poisson model.
    Yang Z; Hardin JW; Addy CL; Vuong QH
    Biom J; 2007 Aug; 49(4):565-84. PubMed ID: 17638291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonparametric estimation and testing in a cure model.
    Laska EM; Meisner MJ
    Biometrics; 1992 Dec; 48(4):1223-34. PubMed ID: 1290799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing for the presence of immune or cured individuals in censored survival data.
    Maller RA; Zhou S
    Biometrics; 1995 Dec; 51(4):1197-205. PubMed ID: 8589219
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.